Jan 19 (Reuters) – Sun Pharmaceutical Industries Limited (SUN.NS), India’s largest drugmaker, said on Thursday it will acquire U.S.-based Concert Pharmaceuticals (CNCE.O) for $576 million in cash to gain access to its experimental drug for treating patchy baldness. The deal is the Indian drugmaker’s biggest…